Preview Mode Links will not work in preview mode

Psychopharmacology and Psychiatry Updates

Jan 28, 2021

What can we conclude from 9 international guidelines addressing the role of antidepressants in the treatment of bipolar depression? Can antidepressants induce treatment resistance? Some authoritative authors say, maybe.

Research editor: James Phelps, M.D.
Hosts: Jessica Diaz, M.D; Flavio Guzman, M.D.


Jan 23, 2021

  • Which antidepressant class is effective for the premenstrual syndromes PMS and PMDD?
  • How can you use antidepressants intermittently to relieve PMS symptoms (luteal-phase and symptom-onset dosing)?
  • Should you prescribe only antidepressants that have been approved by the FDA for PMDD?

Faculty: Lauren Osborne,...


Jan 18, 2021

Atomoxetine is the only non-stimulant medication approved by the FDA for the treatment of ADHD in adults.
We discuss:

  • Its most common and not-so-common side effects.
  • What other non-stimulants you can use.

Faculty: Oscar Bukstein, M.D.
Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.


Jan 13, 2021

  • What is the most helpful and accurate way of understanding premenstrual mood symptoms?
  • What is the preferred scale available? Does it have any limitations?
  • Are period tracking apps useful for diagnosing PMDD?

Faculty: Lauren Osborne, M.D.
Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.


Jan 8, 2021

  • What is preferred: Long-acting or short-acting formulations?
  • What are the general prescribing principles for all psychostimulants?
  • What are their most common side effects?
  • What side effects you should monitor?

Faculty: Oscar Bukstein, M.D.
Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.